National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Health Disorders

The goal of the NCDDG program is to advance the discovery, preclinical development, and early proof of concept testing in humans of new pharmacologic and neuromodulatory approaches to treat mental disorders, and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug and device targets.